Evidence map›Paper›PMID 25794170›Full record

ArticlePloS one2015

The TP73 gene polymorphism (rs4648551, A>G) is associated with diminished ovarian reserve.

Laura Diniz Vagnini, Adriana Renzi, Gabriela Ravanelli Oliveira-Pelegrin, Maria do Carmo Tomitão Canas, Claudia Guilhermino Petersen, Ana Lucia Mauri, João Batista Alcantara Oliveira, Ricardo Luiz Razera Baruffi, Mario Cavagna, José Gonçalves Franco Junior

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Laura Diniz VagniniPaulista Center for Diagnosis, Research and Training, Ribeirão Preto, São Paulo, Brazil.
Adriana RenziPaulista Center for Diagnosis, Research and Training, Ribeirão Preto, São Paulo, Brazil.
Gabriela Ravanelli Oliveira-PelegrinPaulista Center for Diagnosis, Research and Training, Ribeirão Preto, São Paulo, Brazil.
Maria do Carmo Tomitão CanasPaulista Center for Diagnosis, Research and Training, Ribeirão Preto, São Paulo, Brazil.
Claudia Guilhermino PetersenCenter for Human Reproduction Prof. Franco Jr, Ribeirão Preto, São Paulo, Brazil.
Ana Lucia MauriCenter for Human Reproduction Prof. Franco Jr, Ribeirão Preto, São Paulo, Brazil.
João Batista Alcantara OliveiraCenter for Human Reproduction Prof. Franco Jr, Ribeirão Preto, São Paulo, Brazil.
Ricardo Luiz Razera BaruffiCenter for Human Reproduction Prof. Franco Jr, Ribeirão Preto, São Paulo, Brazil.
Mario CavagnaCenter for Human Reproduction Prof. Franco Jr, Ribeirão Preto, São Paulo, Brazil.
José Gonçalves Franco JuniorCenter for Human Reproduction Prof. Franco Jr, Ribeirão Preto, São Paulo, Brazil.
Centro de Reprodução Humana Prof. Franco Junior · BRCentro Paulista de Investigação Clinica · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It's known that the members of the TP53 family are involved in the regulation of female reproduction. Studies in mice showed that the TP73 gene (member of this family) plays a role in the size of follicular pool, ovulation rate and maintenance of genomic stability. In the present study we analyzed data from 605 patients with ≤ 37 years attending their first intracytoplasmic sperm injection (ICSI). The association between the TP73 polymorphism (rs4648551, A>G) and the following parameters related to ovarian reserve, like age, antral follicular count (AFC), anti-Mullerian hormone levels (AMH) and ovarian response prediction index (ORPI) was evaluated. Our results showed an association of the AA genotype with diminished ovarian reserve (AMH <1, AFC ≤9). Women presenting the AA genotype had a 2.0-fold increased risk for having AMH <1 and AFC ≤9 (OR 2.0, 95% CI 1.23-3.31, P = 0.005). Patients presenting AA genotype had the lowest levels of AMH (P = 0.02), the lowest number of antral follicles (P = 0.01) and the lowest ORPI (P = 0.007). Analyzing the alleles, we can see an enrichment of the A allele in the group of diminished ovarian reserve (OR 1.4, 95%CI 1.02-1.83, P = 0.04). To the best of our knowledge, the present study is the first to analyze this polymorphism in humans for assessing the numbers of ovarian follicles and AMH levels and, therefore, the ovarian reserve. Our findings can contribute to the use of this polymorphism as a potential marker of diminished ovarian reserve.

Indexed as

AllelesGenetic Association StudiesPolymorphism, Single NucleotideAdultAnti-Mullerian HormoneBrazilCase-Control StudiesDNA-Binding ProteinsFemaleGene FrequencyGenotypeHumansNuclear ProteinsOvarian FollicleOvarian ReserveOvaryAnti-Mullerian HormoneDNA-Binding ProteinsNuclear ProteinsTP73 protein, humanTrp73 protein, mouseTumor Protein p73Tumor Suppressor Proteins

Identifiers

PMID25794170
PMCPMC4368621
OpenAlexW2139647010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.